MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor δ in human monocytes during the inflammatory response

International Journal of Molecular Medicine

Volumn 31, Issue 5, 2013, Pages 1003-1010

  Thulin, Petra ^a   Wei, Tianling ^a   Werngren, Olivera ^a   Cheung, Louisa ^a   Fisher, Rachel M ^a   Grandér, Dan ^a   Corcoran, Martin ^a   Ehrenborg, Ewa ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Gene regulation; Inflammatory response; Macrophages; MicroRNA 9; Monocytes; Peroxisome proliferator activated receptor

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; LIPOPOLYSACCHARIDE; MICRORNA 9; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

3' UNTRANSLATED REGION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MONOCYTE; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

BASE SEQUENCE; CELLS, CULTURED; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE PROTEINS; MICRORNAS; MOLECULAR SEQUENCE DATA; MONOCYTES; PPAR DELTA; RNA, MESSENGER; THIAZOLES; UP-REGULATION;

EID: 84876106818     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1311     Document Type: Article

References (40)

1. Ehrenborg E and Krook A: Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor δ. Pharmacol Rev 61: 373-393, 2009.
2. Yessoufou A and Wahli W: Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels. Swiss Med Wkly 140: w13071, 2010.
3. Barish GD, Narkar VA and Evans RM: PPARδ: a dagger in the heart of the metabolic syndrome. J Clin Invest 116: 590-597, 2006.
4. Bazzoni F, Rossato M, Fabbri M, et al: Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci USA 106: 5282-5287, 2009.
5. Barroso E, Eyre E, Palomer X and Vázquez-Carrera M: The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1. Biochem Pharmacol 81: 534-543, 2011.
6. Kang K, Reilly SM, Karabacak V, et al: Adipocyte-derived Th2 cytokines and myeloid PPARδ regulate macrophage polarization and insulin sensitivity. Cell Metab 7: 485-495, 2008.
7. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, et al: Alternative M2 activation of kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metab 7: 496-507, 2008.
8. Chinetti-Gbaguidi G, Baron M, Bouhlel MA, et al: Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARgamma and LXRalpha pathways. Circ Res 108: 985-995, 2011.
9. Bouhlel MA, Brozek J, Derudas B, et al: Unlike PPARgamma, PPARalpha or PPARdelta activation does not promote human monocyte differentiation toward alternative macrophages. Biochem Biophys Res Commun 386: 459-462, 2009.
10. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
11. Chekulaeva M and Filipowicz W: Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 21: 452-460, 2009.
12. Dahan O, Gingold H and Pilpel Y: Regulatory mechanisms and networks couple the different phases of gene expression. Trends Genet 27: 316-322, 2011.
13. Martinez-Nunez RT, Louafi F and Sanchez-Elsner T: The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J Biol Chem 286: 1786-1794, 2011.
14. Martinelli R, Nardelli C, Pilone V, et al: miR-519d overexpression is associated with human obesity. Obesity 18: 2170-2176, 2010.
15. Zhou J, Wang K-C, Wu W, et al: MicroRNA-21 targets peroxisome proliferator-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc Natl Acad Sci USA 108: 10355-10360, 2011.
16. Tong JL, Zhang CP, Nie F, et al: MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells. FEBS Lett 585: 3560-3568, 2011.
17. Karbiener M, Fischer C, Nowitsch S, et al: microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem Biophys Res Commun 390: 247-251, 2009.
18. Kim SY, Kim AY, Lee HW, et al: miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun 392: 323-328, 2010.
19. Lee EK, Lee MJ, Abdelmohsen K, et al: miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol 31: 626-638, 2011.
20. Repnik U, Knezevic M and Jeras M: Simple and cost-effective isolation of monocytes from buffy coats. J Immunol Methods 278: 283-292, 2003.
21. Glinghammar B, Skogsberg J, Hamsten A and Ehrenborg E: PPARδ activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells. Biochem Biophys Res Commun 308: 361-368, 2003.
22. Lundell K, Thulin P, Hamsten A and Ehrenborg E: Alternative splicing of human peroxisome proliferator-activated receptor delta (PPARdelta):effects on translation efficiency and trans-activation ability. BMC Mol Biol 8: 70, 2007.
23. Contreras J and Rao DS: MicroRNAs in inflammation and immune responses. Leukemia 26: 404-413, 2012.
24. Wagner K-D and Wagner N: Peroxisome proliferator-activated receptor beta/delta (PPARδ) acts as regulator of metabolism linked to multiple cellular functions. Pharmacol Ther 125: 423-435, 2010.
25. Zhang Y, Liao Y, Wang D, et al: Altered expression levels of miRNAs in serum as sensitive biomarkers for early diagnosis of traumatic injury. J Cell Biochem 112: 2435-2442, 2011.
26. Krichevsky AM, Sonntag K-C, Isacson O and Kosik KS: Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 24: 857-864, 2006.
27. Nie K, Gomez M, Landgraf P, et al: MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol 173: 242-252, 2008.
28. Ma L, Young J, Prabhala H, et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256, 2010.
29. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F and Regazzi R: MicroRNA-9 controls the expression of granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 281: 26932-26942, 2006.
30. Agami R: microRNAs, RNA binding proteins and cancer. Eur J Clin Invest 40: 370-374, 2010.
31. Tan NS, Michalik L, Noy N, et al: Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev 15: 3263-3277, 2001.
32. Delerive P, De Bosscher K, Besnard S, et al: Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 274: 32048-32054, 1999.
33. Guo L-M, Pu Y, Han Z, et al: MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-κB1. FEBS J 276: 5537-5546, 2009.
34. Wan H-Y, Guo L-M, Liu T, Liu M, Li X and Tang H: Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 9: 16, 2010.
35. Wolfs IM, Donners MM and de Winther MP: Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation. Thromb Haemost 106: 763-771, 2011.
36. Lee CH, Chawla A, Urbiztondo N, et al: Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302: 453-457, 2003.
37. Kharroubi I, Lee CH, Hekerman P, et al: BCL-6: a possible missing link for anti-inflammatory PPAR-δ signalling in pancreatic beta cells. Diabetologia 49: 2350-2358, 2006.
38. Chen T, Huang Z, Wang L, et al: MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc Res 83: 131-139, 2009.
39. Peters JM and Gonzalez FJ: Sorting out the functional role(s) of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in cell proliferation and cancer. Biochim Biophys Acta 1796: 230-241, 2009.
40. Mukundan L, Odegaard JI, Morel CR, et al: PPAR-[delta] senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med 15: 1266-1272, 2009.